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WOUND INFECTION RATE IN COLORECTAL SURGERY: A PROSPECTIVE
NON RANDOMIZED TRIAL
Syed Muhammad Amir Zaidi, Wasif Majeed Chaudhry,
Haseeb Anwar Khokhar*, Hamid Majeed, Suhail Aslam Khan. Our Lady of
Lourdes Hospital, Drogheda, Co Louth, Ireland.
Introduction: Negative Pressure Incision care therapy (NPICT) has never
been reported in colorectal surgery. The aim of this trial is to evaluate the
effect of NPICT on wound infection rate.
Methods: 317 consecutive patients underwent major colorectal pro-
cedures in a regional hospital over 3 years by a single team. 104 (32.1%)
patients were excluded on the basis of other complications affecting LOS.
Out of 213 patients included, 71 (33.3%) patients received NPICT, while 142
(66.6%) patients received regular dressings (Non-NPICT group). Study
endpoints were rate of 30-day wound infection rate and LOS.
Results: The mean age was 66.46 (NPICT) and 65.58 (Non-NPICT). Male to
female ratio was 1:1.06(NPICT) and 1:1.04(Non-NPICT). Patients in NPICT
group underwent at least 07 days of incision care therapy. 3 patients (4.2%)
in NPICT group and 29 patients (20.4%) in Non-NPICT group developed
wound complications [p <0.001, RR¼0.68(0.57-0.79), OR¼0.14(0.033-
0.6362)]. The LOS increased from 9±3$22days in the NPICT group and
14±4.31days for Non-NPICT group. Complete healing of wounds occurred
by 31$1±8$22 days in NPICT group.
Conclusions: Use of Negative Pressure Incision care therapy (NPICT)
signiﬁcantly reduces risk of wound infections in high risk colorectal sur-
gical patients thus reducing LOS.
1059: EFFICACY OF ORAL REHYDRATION THERAPY (ORT) IN RESTORING
WATER AND ELECTROLYTE BALANCE POST-COLECTOMY e A BLINDED
PLACEBO-CONTROLLED RANDOMISED CROSS-OVER TRIAL
Sreelakshmi Mallappa*,1, Simon Gabe 1, Robin Phillips 1,
Margaret Robertson 2, Susan Clark 1. 1St Mark's Hospital, Harrow,
Middlesex, UK; 2University of Surrey, Guildford, Surrey, UK.
Introduction: To evaluate the efﬁcacy of oral rehydration therapy (ORT) in
restoring water and electrolyte balance post-colectomy.
Methods: Blinded placebo-controlled randomised cross-over trial. 30
patients with demonstrated hyperaldosteronism from the on-going
observational study were recruited. Patients were randomised to receive
either placebo or ORT ﬁrst in a cross-over trial.
Fasting urine and blood samples were collected to measure sodium loss,
hydration status and renin-angiotensin-aldosterone system (RAAS) acti-
vation. Oral glucose tolerance test was performed. Health related quality of
life (HRQoL) was assessed using SF-36 and FACIT-F questionnaires.
Results: Observational study:60 FAP patients who had undergone
colectomy were recruited. 27 patients (45%) demonstrated fasting
hyperaldosteronism (>250pmol/L) leading to higher urinary losses of
potassium (p¼0.03) and creatinine (p¼0.01). 19 patients 32%) demon-
strated postprandial hypoglycaemia(<3.9mmol/L). Cross-over RCT
Biochemistry results: Data acquired so far in 16 patients (n¼48 clinic
visits) demonstrated fasting plasma aldosterone concentration post-ORT
to be signiﬁcantly lower compared to baseline [189.25 (7.24) vs. 536.25
(12.56) pmol/L; p¼0.05]. HRQoL results: SF 36 & FACIT-F: Post-ORT, pa-
tients reported marked improvement in QoL scores when compared to
baseline.
Conclusions: Colectomy results in metabolic disturbances leading to a
negative impact on Qol. ORT forms a safe and effective intervention to
correct the metabolic disturbances post-colectomy resulting in restoration
of metabolic homeostasis and a positive impact on QoL.
1076: TAKE IT OR LEAVE IT: A MULTI-INSTITUTIONAL STUDY OF MECK-
EL’S DIVERTICULUM
Naomi Fearon*,1, Colin Pierce 1, Helen Mohan 1, Ailin Rogers 1,
Conor Shields 2, Des Winter 1. 1St Vincents University Hospital, Dublin,
Ireland; 2Mater Misericordiae University Hospital, Dublin, Ireland.
Introduction: The management of an incidental Meckels diverticulum
(MD) remains controversial. Current practice guidelines suggests that age
less than 50 years, male sex and diverticulum length greater than 2cm are
factors favouring resection. The aim of this study was to review a regional
experience of resected Meckel's diverticulae.
Methods: All resected specimens over a 17year period (1993-2010) were
identiﬁed from patient clinical records, theatre logbooks, Hospital In-Patient Enquiry data and pathology databases across four hospital sites in
Leinster, Ireland. Patient demographics and clinicopathological charac-
teristics were reviewed.
Results: Ninety-four MD were identiﬁed. The average age at surgery was
43.5 years (range 13-84 years) and 66% of patients were male. Themajority
presented symptomatically (n¼65), with abdominal pain and rectal
bleeding the most common symptoms. Patients presenting symptomati-
cally were signiﬁcantly younger than patients with an incidental ﬁnding of
MD (p¼0.02, Mann-Whitney U test) and 73% of symptomatic patients were
male (p¼0.03, Mann-Whitney U test). Seventy-ﬁve per cent of specimens
were 2cm or greater in length with no difference detected between the
symptomatic and incidental groups. Ectopic mucosa was detected in 21
specimens and no malignancies were detected.
Conclusions: This data suggests the decision to resect should be on an
individual case basis.
1093: A CLINICAL AUDIT OF ENHANCED RECOVERY AFTER SURGERY
(ERAS) PATHWAYS IN COLORECTAL AND HEPATO-PANCREATO-BILLI-
ARY SURGERY AT QUEEN’S MEDICAL CENTRE, NOTTINGHAM UNIVER-
SITY HOSPITAL
Adnan Malik*, Damian Bragg, Charles Maxwell-Armstrong. Queen's
Medical Centre, Nottingham University Hospital, Nottingham, UK.
Introduction: To determine the rate of success of the ERAS pathways in
colorectal and HPB surgery, but also relating compliance and its impact on
ERAS success.
Methods: Pre-, peri- and post-operative data of 56 colorectal and 9 HPB
patients was collected prospectively between October and December 2013.
Primary outcomes of ERAS success (% discharged on or before clinically
expected day) and length of stay (days) were analysed using SPSS version
21.0
Results: ERAS success in colorectal surgery rose to 39.3% after a general
decline from 2010-2012. Mean LOS for open and laparoscopic colorectal
procedures were reduced by 2.8 and 2.6 days respectively. After univariate
analysis 24 protocols were signiﬁcantly associated with colorectal success.
Further multivariate analysis established 12 including PCA or epidural
removal before 12.00am (p¼0.004), urinary catheter removal (p¼0.005)
and length of surgery (p¼0.017). HPB saw a slight drop in ERAS success to
44.4%, only lunch consumption (p¼0.016) was signiﬁcantly associated
with ERAS success after univariate analysis.
Conclusions: Improvement in colorectal ERAS success suggests effective
revision of protocols. As before the HPB results are clinically irrelevant due
to the small sample size. If recommendations put forward are imple-
mented one would expect them to increase future ERAS success.
1116: AVAILABILITY, AND FEASIBILITY OF ROUTINELY MEASURING CO-
MORBIDITY IN A COLORECTAL CANCER MDT
Amin Abukar*, Anthony Ramsanahie, Simon Wong, Kim Martin-Lumbard,
Shaﬁ Ahmed, Mohamed A. Thaha. Academic Surgical Unit, Blizard Institute,
National Centre for Bowel Research & Surgical Innovations (NCBRSI), Barts
and The London SMD, Queen Mary University London, UK, & The Royal London
Hospital, London, UK.
Introduction: With an ageing population diagnosed with cancer, rigorous
co-morbidity assessment is cornerstone to optimising treatment and
improving quality of survivorship. The study primarily aimed to determine
the feasibility of routine co-morbidity data collection using the validated
ACE-27 questionnaire. Secondary aims included determining the optimal
time and method of data collection.
Methods: A retrospective mapping exercise (phase I; 6-months) examined
the co-morbidity data availability within the MDT. Phase II prospectively
collected co-morbidity data using ACE-27 for a 3-month period.
Results: In phase I, 73/135(54%) patients had co-morbidity data available
informing the MDT discussion. In 62-patients with no co-morbidity data,
assessment revealed 41(30%) to have co-morbidities including > 2 major
system disorders in 21(16%) patients. Common referral sources to the MDT
were surgical out-patients (42%), and endoscopy (13%). The average lead
time from referral to index MDT discussion was 14-days. In phase II, ACE-
27 was administered in 50-patients, mean age-54-years (range 20-84).
Male: female ratio 26: 24. Average time to administer ACE-27 was 4.8-
minutes (range 1-15).
Conclusions: The phase I study conﬁrmed the previously widely
acknowledged view of poor co-morbidity data availability within a CRC
